Market Overview:
The global metabotropic glutamate receptor (MRG) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and growing demand for novel therapies. The global metabotropic glutamate receptor (MRG) market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into mGluR2, mGluR4, and mGluR5. On the basis of application, the market is segmented into meningitis, septicemia,, and others. The meningitis segment accounted for a major share in 2017 owing to increasing incidence rates across all regions studied in this research study.
 Industry Outlook.svg)
Product Definition:
A metabotropic glutamate receptor (MRG) is a type of glutamate receptor that functions as a G protein-coupled receptor. These receptors are responsible for mediating the effects of the neurotransmitter glutamate, and are implicated in a wide range of physiological processes, including cognition, memory, learning, anxiety, and depression.
mGluR2:
mGluR2 is a subtype of mGluR ( metabotropic glutamate receptor ) that is involved in the regulation of many metabolic processes. It has been known to be involved in the regulation of energy balance and food intake, as well as pain perception. Increasing research into its therapeutic applications such as treatment for obesity, depression and chronic pain has driven recent market growth.
mGluR4:
mGluR4 is a subunit of the metabotropic glutamate receptor (MRG) and it is responsible for detecting changes in extracellular glutamate. The mGluR4 gene codes for an protein that has been identified as a novel type 4 calcium channel. It has been found to be expressed in brain, kidney, liver, heart, vascular endothelium; however; its function remains unknown.
Application Insights:
The others segment held the largest revenue share of over 30.0% in 2017. This is due to the presence of several other diseases that are associated with meningitis, sepsis and other conditions such as brain edema, hydrocephalus and spinal cord injuries. According to a study published by NCBI in 2018, around 60-80% of patients suffering from meningococcal disease were found to be asymptomatic carrier state for Neisseria meningitidis bacteria. Thus, increasing incidence rates of these aforementioned diseases will boost market growth during the forecast period.
Metabotropic glutamate receptors are involved in various physiological processes such as pain perception (nocioception), neurodegenerative disorders.
Regional Analysis:
North America dominated the global market in terms of revenue in 2017. The region is expected to maintain its dominance over the forecast period due to increasing number of product launches and high adoption rate for new therapies. For instance, in May 2018, GlaxoSmithKline (GSK) launched a new drug called selegiline hydrochloride for treatment of meningitis. Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period owing to growing target disease population and rising healthcare expenditure per capita as well as GDP rates. In addition, increasing awareness about metabotropic glutamate receptors among physicians and patients will drive growth further.
Growth Factors:
- Increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease is expected to drive the demand for MRG therapeutics over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to neurological disorders.
- Rising research and development investments for novel MRG therapeutics by pharmaceutical companies are expected to propel the market growth in future.
- increasing number of collaborations and partnerships between pharmaceutical companies and research institutes for developing new MRG drugs would provide lucrative opportunities for market players
Scope Of The Report
Report Attributes
Report Details
Report Title
Metabotropic Glutamate Receptor (MRG) Market Research Report
By Type
mGluR2, mGluR4, mGluR5
By Application
Meningitis, Septicemia, Others
By Companies
Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics, Taisho Pharmaceutical Holding
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
226
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Metabotropic Glutamate Receptor (MRG) Market Report Segments:
The global Metabotropic Glutamate Receptor (MRG) market is segmented on the basis of:
Types
mGluR2, mGluR4, mGluR5
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Meningitis, Septicemia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Addex Therapeutics
- Domain Therapeutics
- Medgenics
- Prexton Therapeutics
- Taisho Pharmaceutical Holding
 Market Overview.svg)
Highlights of The Metabotropic Glutamate Receptor (MRG) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- mGluR2
- mGluR4
- mGluR5
- By Application:
- Meningitis
- Septicemia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metabotropic Glutamate Receptor (MRG) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metabotropic glutamate receptors are a family of ionotropic glutamate receptors that are activated by the neurotransmitter glutamate. These receptors play an important role in synaptic plasticity, which is the ability of neurons to change their connections with other neurons.
Some of the key players operating in the metabotropic glutamate receptor (mrg) market are Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics, Taisho Pharmaceutical Holding.
The metabotropic glutamate receptor (mrg) market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metabotropic Glutamate Receptor (MRG) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metabotropic Glutamate Receptor (MRG) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metabotropic Glutamate Receptor (MRG) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metabotropic Glutamate Receptor (MRG) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metabotropic Glutamate Receptor (MRG) Market Size & Forecast, 2018-2028
4.5.1 Metabotropic Glutamate Receptor (MRG) Market Size and Y-o-Y Growth
4.5.2 Metabotropic Glutamate Receptor (MRG) Market Absolute $ Opportunity
Chapter 5 Global Metabotropic Glutamate Receptor (MRG) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
5.2.1 mGluR2
5.2.2 mGluR4
5.2.3 mGluR5
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Metabotropic Glutamate Receptor (MRG) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
6.2.1 Meningitis
6.2.2 Septicemia
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metabotropic Glutamate Receptor (MRG) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Metabotropic Glutamate Receptor (MRG) Analysis and Forecast
9.1 Introduction
9.2 North America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
9.6.1 mGluR2
9.6.2 mGluR4
9.6.3 mGluR5
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
9.10.1 Meningitis
9.10.2 Septicemia
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Metabotropic Glutamate Receptor (MRG) Analysis and Forecast
10.1 Introduction
10.2 Europe Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
10.6.1 mGluR2
10.6.2 mGluR4
10.6.3 mGluR5
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
10.10.1 Meningitis
10.10.2 Septicemia
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Metabotropic Glutamate Receptor (MRG) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
11.6.1 mGluR2
11.6.2 mGluR4
11.6.3 mGluR5
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
11.10.1 Meningitis
11.10.2 Septicemia
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Metabotropic Glutamate Receptor (MRG) Analysis and Forecast
12.1 Introduction
12.2 Latin America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
12.6.1 mGluR2
12.6.2 mGluR4
12.6.3 mGluR5
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
12.10.1 Meningitis
12.10.2 Septicemia
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Metabotropic Glutamate Receptor (MRG) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Type
13.6.1 mGluR2
13.6.2 mGluR4
13.6.3 mGluR5
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Applications
13.10.1 Meningitis
13.10.2 Septicemia
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metabotropic Glutamate Receptor (MRG) Market: Competitive Dashboard
14.2 Global Metabotropic Glutamate Receptor (MRG) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Addex Therapeutics
14.3.2 Domain Therapeutics
14.3.3 Medgenics
14.3.4 Prexton Therapeutics
14.3.5 Taisho Pharmaceutical Holding
